FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
October 5, 2018 -- Don't expect much help from FDG-PET/CT results in predicting progression-free or overall survival among patients with peripheral T-cell lymphoma, according to a study published in the October issue of Clinical Lymphoma, Myeloma and Leukemia.
Discuss
October 5, 2018 -- Don't expect much help from FDG-PET/CT results in predicting progression-free or overall survival among patients with peripheral T-cell lymphoma, according to a study published in the October issue of Clinical Lymphoma, Myeloma and Leukemia.
Discuss PET/CT predicts success of rad therapy for spinal mets
October 3, 2018 -- FDG-PET/CT scans can predict the success of radiation therapy in patients with spinal metastases, especially in regard to progression-free survival, according to a study published online September 28 in PLOS One.
Discuss
October 3, 2018 -- FDG-PET/CT scans can predict the success of radiation therapy in patients with spinal metastases, especially in regard to progression-free survival, according to a study published online September 28 in PLOS One.
Discuss PET/MRI motion correction gives readers more confidence
October 2, 2018 -- A motion correction algorithm applied to PET/MRI scans resulted in more accurate scans with fewer false positives, and readers were more confident in their interpretations, according to study results published in the September issue of the Journal of Nuclear Medicine.
Discuss
October 2, 2018 -- A motion correction algorithm applied to PET/MRI scans resulted in more accurate scans with fewer false positives, and readers were more confident in their interpretations, according to study results published in the September issue of the Journal of Nuclear Medicine.
Discuss FDG-PET/CT helps stage men with breast cancer, too
September 26, 2018 -- Assessing breast cancer in men is an uncommon clinical use for FDG-PET/CT, but the hybrid modality achieves results comparable to those in women in regard to accurate staging of the disease, according to a study published online September 21 in the Journal of Nuclear Medicine.
Discuss
September 26, 2018 -- Assessing breast cancer in men is an uncommon clinical use for FDG-PET/CT, but the hybrid modality achieves results comparable to those in women in regard to accurate staging of the disease, according to a study published online September 21 in the Journal of Nuclear Medicine.
Discuss Ga-68 PSMA-11 PET/MRI advances prostate cancer detection
September 25, 2018 -- PET/MRI scans with a gallium-68 (Ga-68)-labeled radiopharmaceutical that homes in on prostate-specific membrane antigen (PSMA)-11 could become a mainstay in prostate cancer detection, given its ability to significantly outperform multiparametric MRI alone, according to a study published online September 18 in Radiology.
Discuss
September 25, 2018 -- PET/MRI scans with a gallium-68 (Ga-68)-labeled radiopharmaceutical that homes in on prostate-specific membrane antigen (PSMA)-11 could become a mainstay in prostate cancer detection, given its ability to significantly outperform multiparametric MRI alone, according to a study published online September 18 in Radiology.
Discuss
Special Feature
Nuclear medicine guidelines promote COVID-19 safety
How can nuclear medicine departments keep patients and staff safe during the COVID-19 pandemic? A new set of guidelines from the IAEA provides some guidance.. Read more
Industry News
VENDOR CONNECT
Conferences
Virtual Vancouver Imaging Review: Head to Toe
September 24-26
Online
September 24-26
Online
American Society of Nuclear Cardiology (ASNC) Annual Scientific Session
September 25-26
Online
September 25-26
Online
World Molecular Imaging Congress (WMIC)
October 7-9
Online
October 7-9
Online
Imaging in the Bahamas
January 18-21, 2021
Nassau, New Providence Bahamas
January 18-21, 2021
Nassau, New Providence Bahamas